An attenuated CMV vaccine with a deletion in tegument protein GP83 (pp65 homolog) protects against placental infection and improves pregnancy outcome in a Guinea pig challenge model

Author： Schleiss Mark R   Buus Ryan J   Choi K Yeon   McGregor Alistair  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.8, Iss.12, 2013-12, pp. : 1151-1160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tale of a tegument transactivator: the past, present and future of human CMV pp71

By Penkert Rhiannon R   Kalejta Robert F  

Future Virology, Vol. 7, Iss. 9, 2012-09 ,pp. : 855-869

Future Medicine

Access to resources Recommend Favorite

Coronavirus vaccine protects against SARS

By  

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Developing a vaccine against congenital CMV infection: what have we learned from animal models? Where should we go next?

By Schleiss Mark R  

Future Virology, Vol. 8, Iss. 12, 2013-12 ,pp. : 1161-1182

Future Medicine

Access to resources Recommend Favorite

The Guinea Pig as an Animal Model for Asthma

By  

Current Drug Targets, Vol. 9, Iss. 6, 2008-06 ,pp. : 452-465

Bentham Science Publishers

Access to resources Recommend Favorite

HPV vaccine protects against cervical cancer precursors

By  

Inpharma, Vol. 1, Iss. 1516, 2005-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite